| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8721763 | Digestive and Liver Disease | 2018 | 7 Pages |
Abstract
Vedolizumab showed good effectiveness after 10 and 22 weeks of treatment. A subset of patients reported improvement also on articular symptoms, probably as a consequence of the concomitant control of gut inflammation.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Fabio Salvatore Macaluso, Rosalba Orlando, Walter Fries, Mariangela Scolaro, Antonio Magnano, Dario Pluchino, Maria Cappello, Gaetano Cristian Morreale, Sebastiano Siringo, Antonino Carlo Privitera, Concetta Ferracane, Nunzio Belluardo, Nadia Alberghina,